Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.I’m joined by Alexander Zehnder, CEO of CureVac — a company that’s been pioneering mRNA technology for 25 years.Alexander stepped into the CEO role in 2023 and has been leading CureVac through a critical transformation: securing a €1.45 billion partnership with GSK, executing a strategic pivot, and driving a major cultural shift within the organization. With a background in medicine and a career spanning Roche, Genentech, and Sanofi, he brings a unique perspective on what it takes to lead at scale while staying patient-focused.We dive into the evolution of mRNA, the story behind CureVac’s next chapter, and the mindset needed to lead through change.Enjoy and stay tuned.
--------
28:33
Episode 45 - Dr. Claudia Zylberberg - Founder of Akron Biotech
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.I’m joined by Dr. Claudia Zylberberg — a pioneering force in cell and gene therapy and the founder of Akron Biotech.Claudia has spent her career shaping the future of biologics manufacturing, building Akron into a key player in the CGT ecosystem, and championing the development of global standards for advanced therapies. She’s a scientist, an entrepreneur, and an advocate for innovation, quality, and access in one of the most complex areas of biotech.From founding startups to influencing international policy, Claudia brings a wealth of experience and insight to the table — and I can’t wait to get into it.Enjoy and stay tuned.
--------
35:12
Episode 44 - Uwe Schoenbeck, Partner of Canaan
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.On this episode of The BioHub, I’m joined by Uwe Schoenbeck, Partner at Canaan and one of the most respected names in early-stage biotech.After more than a decade leading external science and innovation at Pfizer, Uwe made the jump to venture capital, joining Canaan in 2023. With a background spanning big pharma, startups, and science itself—he’s uniquely positioned to see what’s coming next.In this episode, we talk about the shift from pharma to VC, what founders get wrong when pitching, and the traits that separate the good companies from the great ones.Enjoy and stay tuned.
--------
29:28
JP Morgan David Happel
Our little spin off of our time at JPM!Big announcements and exclusives! Here we have David Happel, CEO of Sagimet BiosciencesListen to hear how they've been doing.
--------
8:02
Episode 43 - Gwen Acton, Vivo Group
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. I’m joined by Gwen Acton, CEO of Vivo Group and an expert in leadership development for scientists, engineers, and biotech professionals.Gwen has had a fascinating career—she earned a PhD from MIT, was a faculty member at Harvard, ran operations at the Whitehead Institute during the Human Genome Project, and has helped thousands of technical experts become stronger leaders.Now, she’s adding “author” to her resume with a brand-new book on leadership, and today, we’re diving into why leadership is so crucial in biotech, how it’s evolved, and what inspired her to write it.Enjoy and stay tuned
Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape.
Subscribe now and be part of the conversation that's shaping the future of biotechnology.
Get ready for an immersive experience into the world of biotech with The BioHub.
Sverige